These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13860985)

  • 1. [On the attenuation of toxic preparations from the group of alkylating agents with the aid of dibazol].
    AMIROV RO
    Vopr Onkol; 1962; 8(2)():7-12. PubMed ID: 13860985
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of L-cysteine hydrochloride to protect against the lethal effects of various alkylating agents.
    BALLA GA; FINNEY J; HUTTON SB; MALLAMS JT; SHORT RF
    Am Surg; 1962 Jun; 28():339-41. PubMed ID: 13864419
    [No Abstract]   [Full Text] [Related]  

  • 3. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. II. THERAPEUTIC ACTIVITIES OF ALKYLATING AGENTS AND REFERENCE COMPOUNDS AGAINST VARIOUS TUMOR SYSTEMS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:403+. PubMed ID: 14278902
    [No Abstract]   [Full Text] [Related]  

  • 4. Effective use of a new alkylating agent in children with protection by tourniquets of marrow in the extremities.
    SELIGMAN AM
    Sinai Hosp J (Balt); 1961; 10():91-4. PubMed ID: 13910424
    [No Abstract]   [Full Text] [Related]  

  • 5. [CYTOSTATIC THERAPY WITH ALKYLATING AGENTS FOR MALIGNANT TUMORS].
    SCHUMACHER K; LANGE J
    Dtsch Med J; 1964 Nov; 15():761-5. PubMed ID: 14329920
    [No Abstract]   [Full Text] [Related]  

  • 6. [REPERCUSSIONS OF NEUROLEPTIC AND ANTITUMOR AGENTS ON PRENATAL DEVELOPMENT].
    TUCHMANN-DUPLESSIS H; MERCIER-PAROT L
    Bull Schweiz Akad Med Wiss; 1964 Sep; 20():490-526. PubMed ID: 14192394
    [No Abstract]   [Full Text] [Related]  

  • 7. [INFLUENCE OF ALKYLATING ANTINEOPLASTIC AGENTS ON NARCOSIS].
    DIMEZZA F
    Minerva Anestesiol; 1964 Dec; 30():511-7. PubMed ID: 14267928
    [No Abstract]   [Full Text] [Related]  

  • 8. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. I.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1-401. PubMed ID: 14278901
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxicity from certain brominated alkylating agents.
    MURRAY JF; FINK A
    Arch Environ Health; 1962 Jul; 5():5-11. PubMed ID: 14477467
    [No Abstract]   [Full Text] [Related]  

  • 10. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the effect of dibazol on the phagocytosis and functional condition of the reticuloendothelial system].
    KAPITANENKO AM
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Aug; 33():69-73. PubMed ID: 14453705
    [No Abstract]   [Full Text] [Related]  

  • 12. [COMPARATIVE STUDY OF THE SPECTRUM OF ACTION OF ANTINEOPLASTIC PREPARATIONS OF THE ALKYLATING AGENT GROUP ON TRANSPLANTABLE TUMORS IN MICE].
    BOKAEVA SS
    Biull Eksp Biol Med; 1965 Mar; 59():86-8. PubMed ID: 14310877
    [No Abstract]   [Full Text] [Related]  

  • 13. [MUTAGENIC AND CANCERIGENIC ACTIONS OF ALKYLATING AGENTS].
    VERLY WG
    Rev Fr Etud Clin Biol; 1964 Oct; 9():878-83. PubMed ID: 14226831
    [No Abstract]   [Full Text] [Related]  

  • 14. [The state of nonspecific increase in resistance of animals during muscular training and training with a single administration of dibazol].
    RUSIN VIa
    Patol Fiziol Eksp Ter; 1962; 6():49-53. PubMed ID: 14495362
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE INFLUENCE OF PRELIMINARY TREATMENT OF RATS WITH ALKYLATING SUBSTANCES AND OTHER TOXINS ON THE GROWTH OF YOSHIDA SARCOMA].
    SCHMAEHL D; SATTLER W
    Arzneimittelforschung; 1964 Jul; 14():746-50. PubMed ID: 14344711
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of the adaptation to low temperatures and dibazol in increased resistance of mice to adverse factors].
    RUSIN VIa
    Fiziol Zh SSSR Im I M Sechenova; 1962 Feb; 48():195-200. PubMed ID: 14495361
    [No Abstract]   [Full Text] [Related]  

  • 17. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON THE CARCINOSTATIC EFFECTS OF AMINOALKYLATING COMPOUNDS. 1. ON CYTOSTATICS].
    SCHOENENBERGER H; ADAM A
    Arzneimittelforschung; 1964 Oct; 14():1168. PubMed ID: 14343486
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticancer, antispasmodic, anticholinergic drugs named.
    SCHWARTZ H; DELGADO JN
    Tex State J Med; 1960 Jan; 56():50-1. PubMed ID: 14443980
    [No Abstract]   [Full Text] [Related]  

  • 20. CURRENT THERAPEUTICS. CCXII. ETHOGLUCID.
    CLARKE SD
    Practitioner; 1965 Aug; 195():243-8. PubMed ID: 14323890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.